BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15541764)

  • 1. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J; Mongan NP; Harland S; Hughes IA
    Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
    Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
    J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits.
    Werner R; Zhan J; Gesing J; Struve D; Hiort O
    Sex Dev; 2008; 2(2):73-83. PubMed ID: 18577874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
    Bonagura TW; Deng M; Brown TR
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.
    Deeb A; Mason C; Lee YS; Hughes IA
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):56-62. PubMed ID: 15963062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Chávez B; Méndez JP; Ulloa-Aguirre A; Larrea F; Vilchis F
    J Hum Genet; 2001; 46(10):560-5. PubMed ID: 11587068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
    Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.
    Radmayr C; Culig Z; Glatzl J; Neuschmid-Kaspar F; Bartsch G; Klocker H
    J Urol; 1997 Oct; 158(4):1553-6. PubMed ID: 9302173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterisation of a natural androgen receptor missense mutation (N771H) causing human androgen insensitivity syndrome.
    Cai J; Cai LQ; Hong Y; Zhu YS
    Andrologia; 2012 May; 44 Suppl 1():523-9. PubMed ID: 21950590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L859F mutation in androgen receptor gene results in complete loss of androgen binding to the receptor.
    Rajender S; Singh L; Thangaraj K
    J Androl; 2007; 28(5):772-6. PubMed ID: 17522416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.